All Pharma News
Hansa Biopharma interim report January-March 2024

Hansa Biopharma interim report January-March 2024
PR NEWSWIRE
18 Apr 2024
Share Share
Hansa Biopharma Expects Strong First Quarter 2024 Sales Performance

Hansa Biopharma Expects Strong First Quarter 2024 Sales Performance
PR NEWSWIRE
02 Apr 2024
Share Share
Hansa Biopharma Year-end report January-December 2023

Hansa Biopharma Year-end report January-December 2023
PR NEWSWIRE
01 Feb 2024
Share Share
Hansa Biopharma provides update on business

Hansa Biopharma provides update on business
PR NEWSWIRE
07 Jan 2024
Share Share
Imlifidase met primary endpoint in 16-HMedIdes-12 phase 2 in patients with AMR

Imlifidase met primary endpoint in 16-HMedIdes-12 phase 2 in patients with AMR
PR NEWSWIRE
14 Dec 2023
Share Share
Hansa Biopharma Nomination Committee formed

Hansa Biopharma Nomination Committee formed
PR NEWSWIRE
13 Dec 2023
Share Share
Imlifidase demonstrated positive safety efficacy outcomes phase 2 trial in GBS

Imlifidase demonstrated positive safety efficacy outcomes phase 2 trial in GBS
PR NEWSWIRE
06 Dec 2023
Share Share
Hansa Biopharma plans restructuring

Hansa Biopharma plans restructuring
PR NEWSWIRE
05 Dec 2023
Share Share
Hansa Biopharma Interim Report January-September 2023

Hansa Biopharma Interim Report January-September 2023
PR NEWSWIRE
26 Oct 2023
Share Share
Hansa Biopharma Names Hitto Kaufmann Chief Scientific Officer

Hansa Biopharma Names Hitto Kaufmann Chief Scientific Officer
CONTRACT PHARMA
01 Sep 2023
Share Share